While there was no difference between patients with RA and SLE in the frequency of activated NK cells that lacked CD16 expression and/or expressed CD107a, NK cells from patients with both RA and SLE responded less well to stimulation with RTX compared with OBZ. The gene discussed is FCGR3B; the disease is rheumatoid arthritis.